Abstracts tagged "Neuroimaging"

Abstract Number: 630 • 2012 ACR/ARHP Annual Meeting
Risk Factors Associated with Early Central Nervous System Damage Detected Through Diffusion Tensor Imaging (DTI) in Patients with Systemic Lupus Erythematosus
Paola Tomietto¹, Federica Casagrande², Maja Ukmar³, Luca Weis⁴, Pia Morassi⁵, Rita Moretti⁶, Gianni Biolo⁶, Carlo Giansante⁷ and Maria Assunta Cova⁸, ¹Internal Medicine Department, AOU Ospedali Riuniti, Trieste, Italy, ²Radiology department, University of Trieste, Trieste, Italy, ³Radiology Department, University of Trieste, Trieste, ⁴Radiology Department, University of Trieste, Trieste, Italy, ⁵Internal Medicine Department, AOU Ospedali Riuniti di Trieste, Trieste, Italy, ⁶Internal Medicine Department, University of Trieste, Trieste, Italy, ⁷Internal Medicine epartment, University of Trieste, Trieste, Italy, ⁸Department of Radiology, University of Trieste, Trieste, Italy
Background/Purpose: Antiphosholipid antibodies, SLICC-DI and some cardiovascular risk factors have been identified as risk factors for neuropsychiatric lupus (NPSLE). Diffusion tensor imaging (DTI) is an…
Abstract Number: 306 • 2012 ACR/ARHP Annual Meeting
Children with Probable SLE by ACR Criteria May Need More Aggressive Lupus Treatment Early in the Disease Course
Anjali Patwardhan¹, Igor Dvorchik² and Charles H. Spencer³, ¹Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, ²Biostatistics Division, Nationwide Children's Hospital,, Columbus, OH, ³Rheumatology, Nationwide Childrens Hospital, Columbus, OH
Background/Purpose: This research explores whether delay of the childhood-onset SLE (cSLE) diagnosis until 4/11 ACR criteria are met affects patient outcome negatively Methods: Institutional Review…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].